Skip to main navigation
Skip to search
Skip to main content
The Rotterdam Eye Hospital and Rotterdam Ophthalmic Institute Home
English
Nederlands
Search content at The Rotterdam Eye Hospital and Rotterdam Ophthalmic Institute
Home
Research output
Profiles
Activities
Press/Media
Research units
Infliximab for IgG4-Related Orbital Disease
Faiz Karim
,
D Paridaens
, L E H Westenberg
, J Guenoun
, R M Verdijk
, P M van Hagen
, J A M van Laar
Orbita and oculoplastic surgery
Research output
:
Contribution to journal
›
Letter
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Infliximab for IgG4-Related Orbital Disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Disease
60%
Fibrosis
20%
IgG4-Related Disease
100%
Immunoglobulin G4
100%
Immunosuppressive Drug
40%
Infliximab
100%
Orbit Disease
100%
Orbital Inflammation
20%
Pathophysiology
20%
Trismus
20%
Tumor Necrosis Factor
60%
Visual Impairment
20%
Keyphrases
Epilepsy
20%
Fibroinflammatory Disease
20%
Fibrosis
20%
Idiopathic Orbital Inflammation
20%
IgG4-related Disease (IgG4-RD)
100%
IgG4-related Orbital Disease
100%
Immunosuppressive Agents
40%
Infliximab
100%
Maintenance Strategy
20%
Multi-organ
20%
Older Women
20%
Pathophysiology
20%
Steroid-sparing
20%
TNF Blockers
40%
Trismus
20%
Tumor Necrosis Factor-α
20%
Vision Loss
20%